← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


Learn about Oligonucleotide Metabolite Identification, learn about QPS' proprietary GLP-1 and IgG assays, and catch up on the latest scientific insights and breakthroughs on the QPS blog.



Therapeutic Oligonucleotide Metabolite Identification

Therapeutic oligonucleotides are being developed for cancer, viral, autoimmune and neurodegenerative diseases. New delivery platforms such as mRNA, circular RNA and RNA micelles introduce complex analytical challenges.


As these therapies advance, bioanalytical methods must evolve to meet regulatory demands. QPS is a full service CRO that provides a full range of bioanalytical services to support all oligonucleotide development.


Explore the QPS white paper showcasing cutting-edge methods for metabolite identification, profiling, and quantitation in therapeutic oligonucleotides.

Download the White Paper

Oligonucleotide Metabolite Identification, Profiling and Quantitation


QPS Proprietary GLP-1 and IgG Assays

GLP-1 receptor agonists are now among the fastest-growing therapeutic classes, with semaglutide supporting an expanding range of clinical programs. Our lab offers a proprietary semaglutide assay designed for accurate, reproducible bioanalysis across development stages.



Accurate pharmacokinetic profiling of monoclonal antibodies via LC-MS/MS bioanalysis is critical for dose selection and safety assessment. Our proprietary IgG 1 and IgG 4 assays deliver robust quantification across the full PK curve, supporting accurate exposure assessment.

Discover the Future of Science on the QPS Blog

Cavities and Gum Disease Double Stroke Risk

 

Periodontal disease, more commonly known as gum disease, is a global problem. Severe cases impact more than one billion people around the world, with…



Teeth, Gums, and Ischemic Stroke Risk

Preclinical Services at QPS

When Old Diseases Roar Back: Understanding Diphtheria’s Resurgence

 

Diphtheria is a preventable bacterial disease that causes a thick membrane to form in the back of the throat, making swallowing and breathing difficult….

 

Strain on an Already Fractured System

See More Therapeutic Area Blog Posts

Contact the Experts at QPS

 

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today. 

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

Linkedin  Youtube  X  Facebook

View as Webpage

www.qps.cominfopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive